telaprevir

ThinkEquity LLC analyst Brian Skorney maintained his Hold rating for shares of Vertex Pharmaceuticals Inc. (Nasdaq: VRTX). Skorney wrote that he maintained his Hold rating for Vertex Pharmaceuticals Inc. because he thought that shares of the biotechnology company were fairly valued. Although...